4//SEC Filing
DALZIEL BRUCE D 4
Accession 0001181431-11-061150
CIK 0001107216other
Filed
Dec 18, 7:00 PM ET
Accepted
Dec 19, 4:51 PM ET
Size
7.6 KB
Accession
0001181431-11-061150
Insider Transaction Report
Form 4
DALZIEL BRUCE D
Director
Transactions
- Disposition to Issuer
Stock Option (Right to Buy)
2011-12-15$2.80/sh−61,882$173,270→ 0 totalExercise: $1.88Exp: 2020-04-01→ Common Stock (61,882 underlying) - Disposition to Issuer
Stock Option (Right to Buy)
2011-12-15$2.80/sh−18,439$51,629→ 0 totalExercise: $2.03Exp: 2020-05-05→ Common Stock (18,439 underlying)
Footnotes (2)
- [F1]This option was cancelled in exchange for a cash payment of $56,931, representing the difference between the exercise price of the option and the offer price ($2.80 per share) pursuant to the Agreement and Plan of Merger between Laboratory Corporation of America Holdings, OCM Acquisition Corp. and Orchid Cellmark Inc., dated as of April 5, 2011, as amended (the "Merger Agreement").
- [F2]This option was cancelled in exchange for a cash payment of $14,198, representing the difference between the exercise price of the option and the offer price ($2.80 per share) pursuant to the Merger Agreement.
Documents
Issuer
ORCHID CELLMARK INC
CIK 0001107216
Entity typeother
Related Parties
1- filerCIK 0001237855
Filing Metadata
- Form type
- 4
- Filed
- Dec 18, 7:00 PM ET
- Accepted
- Dec 19, 4:51 PM ET
- Size
- 7.6 KB